{
    "clinical_study": {
        "@rank": "63833", 
        "arm_group": [
            {
                "arm_group_label": "Oral midazolam", 
                "arm_group_type": "Active Comparator", 
                "description": "Oral midazolam (5 mg) in 15 mL of apple juice was drunk 30 minutes before EGD"
            }, 
            {
                "arm_group_label": "Apple juice", 
                "arm_group_type": "Placebo Comparator", 
                "description": "15 mL of apple juice was drunk 30 minutes before EGD"
            }
        ], 
        "brief_summary": {
            "textblock": "Can oral midazolam used for sedation in patients undergoing upper gastrointestinal endoscopy\n      ?"
        }, 
        "brief_title": "Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD)", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Conscious Sedation Failure During Procedure", 
        "detailed_description": {
            "textblock": "Five mg of midazolam was intake orally about 30 minutes before undergoing perform upper\n      gastrointestinal endoscopy. Declined of anxiety scores was primary end point."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Scheduled to undergo elective diagnostic EGD\n\n          -  American Society of Anesthesia (ASA) criteria to be class 1 to 2\n\n        Exclusion Criteria:\n\n          -  History of gastrectomy, esophagectomy, pancreaticoduodenectomy, or other operation on\n             the upper-GI tract\n\n          -  American Society of Anesthesia (ASA) criteria to be class  3 to 4\n\n          -  Pregnancy\n\n          -  Alcoholism\n\n          -  Drug abuse\n\n          -  Taking psychotic medications\n\n          -  Allergy to midazolam."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "260", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01990937", 
            "org_study_id": "PMK-031"
        }, 
        "intervention": {
            "arm_group_label": "Oral midazolam", 
            "description": "5 mg in 15 mL of apple juice, orally 30 minutes before undergoing EGD", 
            "intervention_name": "Oral midazolam", 
            "intervention_type": "Drug", 
            "other_name": "Dormicum"
        }, 
        "intervention_browse": {
            "mesh_term": "Midazolam"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oral midazolam", 
            "sedation", 
            "premedication", 
            "upper gastrointestinal endoscopy", 
            "EGD"
        ], 
        "lastchanged_date": "November 16, 2013", 
        "location": {
            "contact": {
                "email": "iamkeang@hotmail.com", 
                "last_name": "Chaipichit Puttapitakpong, Doctor", 
                "phone": "6681707-3005"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10400"
                }, 
                "name": "Division of Gastroenterology, Department of Medicine, Phramongkutklao hospital"
            }, 
            "investigator": {
                "last_name": "Chaipichit Puttapitakpong, Doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of Oral Midazolam for Sedation in Patients Undergoing Upper Gastrointestinal Endoscopy", 
        "other_outcome": [
            {
                "description": "Fully recovery means fully gain of consiouness (time, place, person).\nAmnesia score was grading into 4 levels;\n= Patient unable to recall any portion of procedure\n= Able to recall and describe some portion of procedure\n= Able to recall and describe most of procedure\n= Able to recall and describe entire procedure", 
                "measure": "Amnesia score", 
                "safety_issue": "No", 
                "time_frame": "Asked the patient after fully recovery from sedation."
            }, 
            {
                "description": "Fully recovery means fully gain of consiouness (time, place, person). Overall satifaction was 10-cm scaled visual analog scale.", 
                "measure": "Overall satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Asked the patient after fully recovery from sedation."
            }, 
            {
                "description": "Fully recovery means fully gain of consiouness (time, place, person). Willing to repeat EGD was defined to \"Yes or No\".", 
                "measure": "Willing to repeat EGD", 
                "safety_issue": "No", 
                "time_frame": "Asked the patient after fully recovery from sedation."
            }, 
            {
                "description": "Vital signs were blood pressure(mmHg), heart rates(beats per minute), respiratory rates(per minute) and oxygen saturation(percents).", 
                "measure": "Vital signs", 
                "safety_issue": "Yes", 
                "time_frame": "Vital signs were measured at 5 minutes before EGD then measured every 5 minutes during EGD until the patient was fully recovery after the EGD was finished."
            }
        ], 
        "overall_contact": {
            "email": "iamkeang@hotmail.com", 
            "last_name": "Chaipichit Puttapitakpong, Doctor", 
            "phone": "6681707-3005"
        }, 
        "overall_official": {
            "affiliation": "Division of gastroentrology, Department of Medicine, Phramongkutklao hospital", 
            "last_name": "Chaipichit Puttapitakpong, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Anxiety score is 10-cm scaled visual analog scale.\nAnxiety score which asked the patient 5 minutes before EGD, called \"Pre EGD anxiety score\"\nAnxiety score which asked the patient after fully recovery, called \"During EGD anxiety score\".\nDifference of anxiety score means \"Pre EGD minus During anxiety score\".\nFully recovery means fully gain of consiouness (time, place, person).", 
            "measure": "Difference of Anxiety score", 
            "safety_issue": "No", 
            "time_frame": "Asked the patient 5 minutes before EGD and then after fully recovery from sedation."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01990937"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Fully recovery means fully gain of consiouness (time, place, person).\nOverall tolerance was grading into 4 levels;\nPoor : Very uncomfortable during the entire procedure\nFair : Uncomfortable during most of the procedure\nGood : Believes the procedure was generally comfortable, there were portions of procedure during  which sedation could have been given\nExcellent : Believes the procedure was comfortable, no additional sedation was needed", 
            "measure": "Overall tolerance", 
            "safety_issue": "No", 
            "time_frame": "Asked the patient after fully recovery from sedation."
        }, 
        "source": "Phramongkutklao College of Medicine and Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Phramongkutklao College of Medicine and Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}